Evaluation of efficacy and safety of improved transurethral plasma kinetic enucleation of the prostate in high-risk patients with benign prostatic hyperplasia and coronary artery disease

Abstract

Objective This prospective study aimed to evaluate the safety of improved transurethral plasma kinetic enucleation of the prostate (iTUPKEP) in the perioperative period in high-risk patients with benign prostatic hyperplasia (BPH) and coronary artery disease. Methods Patients with BPH underwent surgical treatment with transurethral vapour resection of the prostate (TUVP) or iTUPKEP. Serum endothelin-1, cardiac troponin-I, and high-sensitivity C-reactive protein concentrations were evaluated in the short term after surgery. The postvoid residual urine volume, maximum urinary flow rate, international prostate symptom score, and quality of life indicators were evaluated in the long term after surgery. Results Endothelin-1 concentrations were lower in the iTUPKEP group than in the TUVP group at 1 and 2 days postoperatively. The iTUPKEP group had lower cardiac troponin-I and high-sensitivity C-reactive protein concentrations at all time points postoperatively. The postvoid residual urine volume, international prostate symptom score, and quality of life values were lower, but the maximum urinary flow rate was higher, in the iTUPKEP group than in the TUVP group. Conclusions The iTUPKEP procedure has a smaller effect on vascular endothelial function compared with TUVP. Therefore, iTUPKEP may reduce the incidence of postoperative cardiovascular adverse events in high-risk patients with BPH and coronary artery disease.

Influence of High-Protein Food on Physical Function of Athletes

“…Modern basketball is constantly innovating and developing, the competition between international strong teams is becoming more and more intense, and the requirements for athletes' physical fitness are getting higher and higher [3]. An athlete's physical potential must be maximized in order for it to be capable of conquering opponents.…”

Transurethral 1470 nm diode laser vaporization versus plasma kinetic enucleation of the prostate for the treatment of benign prostatic hyperplasia: A retrospective study

“…Both procedures resulted in significant improvements in IPSS, QoL, Qmax and PVR at the 24-month follow-up, consistent with previous studies involving transurethral 1470 nm diode laser vaporization [17,18] and PKEP. [19][20][21][22] Transurethral 1470 nm diode laser vaporization was associated with significantly less intraoperative blood loss. Indeed, the effectiveness of the laser in vaporizing, cutting and coagulating prostate tissue primarily depends on the laser wavelength.…”

“…Both procedures resulted in significant improvements in IPSS, QoL, Qmax and PVR at the 24-month follow-up, consistent with previous studies involving transurethral 1470 nm diode laser vaporization [17,18] and PKEP. [19–22]…”

Efficacy and Safety of Prostatic Artery Embolization in the Treatment of High Risk Benign Prostatic Hyperplasia and its Influence on Postoperative Life Quality of Patients

“…With the accelerated aging of the population, the incidence of benign prostatic hyperplasia (BPH) is increasing among elderly men in China ( 1 ). Histologically, BPH is mainly characterized by hyperplasia of prostatic interstitial and glandular components, anatomically, enlarged prostate, which often leads to lower urinary tract symptoms, such as dysuria, frequent urination, urinary incontinence, etc ( 2 , 3 ). Long-term development of the disease will cause serious damage to the bladder and kidney function, and have many adverse effects on patients’ quality of life.…”